# Single Dose Study of N1539 in the Treatment of Pain Secondary to Dental Impaction Surgery

> **NCT00945763** · PHASE2 · COMPLETED · sponsor: **Alkermes, Inc.** · enrollment: 230 (actual)

## Conditions studied

- Dental Pain

## Interventions

- **DRUG:** N1539
- **DRUG:** placebo
- **DRUG:** N1539
- **DRUG:** N1539
- **DRUG:** Motrin

## Key facts

- **NCT ID:** NCT00945763
- **Lead sponsor:** Alkermes, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2009-11
- **Final completion:** 2009-11
- **Target enrollment:** 230 (ACTUAL)
- **Last updated:** 2011-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00945763

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00945763, "Single Dose Study of N1539 in the Treatment of Pain Secondary to Dental Impaction Surgery". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00945763. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*